Is Puma Biotechnology a Buy?

What’s the deal with this battered breast cancer biotech and is it a good deal? Puma Biotechnology (NASDAQ:PBYI) used to be a pretty compelling investment for many biotech investors out there. Its only drug, Nerlynx (also known as neratinib), targets a significant portion of the breast cancer patient population and definitely has the potential to be…

Links 1/8/2020

Woman rescued after being stuck inside clothing donation bin for 3 days Good Morning America The Year and the Decade in Weather and Climate: A Meta-Lookback Weather Underground Ross Garnaut’s climate change prediction is coming true and it’s going to cost Australia billions, experts warn ABC Australia Australia’s leaders unmoved on climate action after devastating…